Drug Chatter -- Tracking biopharma stock chatter

Profile for Fate Therapeutics, Inc. (FATE)

« Back to company index

FATE Chatter Timeline

Stock Ticker for FATE

Most Active Tweeters for FATE

UserTweets
@tribepublic 5
@JasonHolman5 5
@VistaPResearch 5
@ConsumerFeed 4
@dispatchtribune 4

Recent Tweets for FATE

ThisLincolnian @ThisLincolnian
$2.02 Million in Sales Expected for Fate Therapeutics $FATE This Quarter https://t.co/b13nWx85FU
April 23rd 2018, 6:04am
dispatchtribune @dispatchtribune
Somewhat Positive News Coverage Somewhat Unlikely to Impact Fate Therapeutics $FATE Share Price https://t.co/OWk0wXWk9D
April 23rd 2018, 3:04am
EnterpriseLeade @EnterpriseLeade
Somewhat Positive News Coverage Somewhat Unlikely to Affect Fate Therapeutics $FATE Stock Price https://t.co/Ht5n5tC11I
April 23rd 2018, 3:04am
storminvestor @storminvestor
$2.02 Million in Sales Expected for Fate Therapeutics $FATE This Quarter https://t.co/6oykVfY5WC
April 23rd 2018, 3:04am
TranscriptDaily @TranscriptDaily
Zacks: Analysts Anticipate Fate Therapeutics $FATE Will Announce Quarterly Sales of $2.02 Million https://t.co/OgR3Znbjs4
April 23rd 2018, 3:04am
JasonHolman5 @JasonHolman5
$FATE ... really like the promise of their OTS approach leveraging induced pluripotent stem cell lines. https://t.co/YkHV7SRK5r
April 22nd 2018, 6:04pm
registrarjourn @registrarjourn
Brokerages Set Fate Therapeutics $FATE Target Price at $16.17 https://t.co/RfrPPXVeM6
April 21st 2018, 11:04pm
ThisLincolnian @ThisLincolnian
-$0.22 EPS Expected for Fate Therapeutics $FATE This Quarter https://t.co/3wD7YT4WWV
April 21st 2018, 3:04pm
AmericanBanking @AmericanBanking
-$0.22 EPS Expected for Fate Therapeutics $FATE This Quarter https://t.co/YFR52PmLZs #stocks
April 21st 2018, 3:04pm
VistaPResearch @VistaPResearch
RT @tribepublic: Fate Therapeutics $FATE spoke with #investors in Minneapolis today. Want to meet Fate Therapeutics in your City? Learn how…
April 21st 2018, 11:04am
ConsumerFeed @ConsumerFeed
Brokerages Set Fate Therapeutics $FATE Target Price at $16.17 https://t.co/zHriOQzIBh
April 19th 2018, 6:04pm
ThisLincolnian @ThisLincolnian
Fate Therapeutics $FATE Receives $16.17 Average Price Target from Analysts https://t.co/Uy9JXk1xRv
April 19th 2018, 6:04pm
tribepublic @tribepublic
Fate Therapeutics $FATE spoke with #investors in Minneapolis today. Want to meet Fate Therapeutics in your City? Le… https://t.co/Tarpla7G1Y
April 19th 2018, 1:04pm
thomaspan @thomaspan
RT @ZorTrades: $FATE coling for a 2nd try https://t.co/GkxgtGJJn8
April 19th 2018, 10:04am
ZorTrades @ZorTrades
$FATE coling for a 2nd try https://t.co/GkxgtGJJn8
April 19th 2018, 10:04am
VistaPResearch @VistaPResearch
RT @tribepublic: Fate Therapeutics $FATE spoke with #investors in Chicago today. Want to meet Fate Therapeutics in your City? Learn how at…
April 19th 2018, 12:04am
tribepublic @tribepublic
Fate Therapeutics $FATE spoke with #investors in Chicago today. Want to meet Fate Therapeutics in your City? Learn… https://t.co/d6dLzsztgz
April 18th 2018, 3:04pm
365Investing @365Investing
RT @ZorTrades: $FATE swing of interest thru yday's high https://t.co/MRv4i9APtD
April 18th 2018, 11:04am
CaesarBiotech @CaesarBiotech
RT @JasonHolman5: https://t.co/Qa49rf1G9F $FATE updated Corp. Pres.,comprehensive. Pgms across both I-O&Immuno Reg,1st slide on APOLLO data…
April 18th 2018, 9:04am
ZorTrades @ZorTrades
$FATE swing of interest thru yday's high https://t.co/MRv4i9APtD
April 18th 2018, 7:04am
OlympiaReport @OlympiaReport
Fate Therapeutics $FATE Getting Somewhat Positive News Coverage, Study Shows https://t.co/1fu4LhIRzs
April 18th 2018, 3:04am
dispatchtribune @dispatchtribune
Fate Therapeutics $FATE Receives Coverage Optimism Score of 0.17 https://t.co/fNyDw0R0EH
April 18th 2018, 3:04am
rhoman1996 @rhoman1996
RT @upsidetrader: $FATE popped above downtrend last week, now flagging , looks 12.50-14.00 https://t.co/m2ApjzIiVu
April 17th 2018, 8:04pm
Abkon187 @Abkon187
RT @AmyAtrade: $FATE long setup https://t.co/sg3KmIdnap
April 17th 2018, 6:04pm
AmyAtrade @AmyAtrade
$FATE long setup https://t.co/sg3KmIdnap
April 17th 2018, 5:04pm
upsidetrader @upsidetrader
$FATE popped above downtrend last week, now flagging , looks 12.50-14.00 https://t.co/m2ApjzIiVu
April 17th 2018, 1:04pm
ok_trader @ok_trader
$FATE watching tight pattern https://t.co/iHOWqcruvS
April 17th 2018, 1:04pm
VistaPResearch @VistaPResearch
RT @tribepublic: $FATE Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR Annual Meeting…
April 17th 2018, 12:04pm
dailypoliticaln @dailypoliticaln
Brokerages Set Fate Therapeutics $FATE Target Price at $16.17 https://t.co/HeTz5YATgB
April 17th 2018, 9:04am
ledgerzette @ledgerzette
Fate Therapeutics $FATE Receives $16.17 Average Price Target from Analysts https://t.co/xfB1HTYoYv
April 17th 2018, 9:04am
bdailystocks @bdailystocks
$FATE $ 11.15 USD -0.39 (3.38%) - News Out on Fate Therapeutics https://t.co/ZVO8NPdMne
April 16th 2018, 10:04pm
Aesculapius1898 @Aesculapius1898
RT @JasonHolman5: From new $FATE Corp. Pres., although mgnt focusing on I-O oncology; am excited to see if they bring Toleracyte to the cli…
April 16th 2018, 10:04pm
Hall8Jack @Hall8Jack
RT @BoerseGer: $FATE Presentation: https://t.co/ETZh8fM1RT Poster: https://t.co/n2HbsgHr43
April 16th 2018, 6:04pm
JasonHolman5 @JasonHolman5
From new $FATE Corp. Pres., although mgnt focusing on I-O oncology; am excited to see if they bring Toleracyte to t… https://t.co/xqaLg5RBvs
April 16th 2018, 5:04pm
BoerseGer @BoerseGer
$FATE Presentation: https://t.co/ETZh8fM1RT Poster: https://t.co/n2HbsgHr43
April 16th 2018, 2:04pm
danrocks4 @danrocks4
FATE is number 58 for the largest percentage gain out of 100 stocks. $FATE Fate Therapeutics is up +18.78% in https://t.co/vFoalUC29K
April 16th 2018, 2:04pm
tribepublic @tribepublic
$FATE Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR Annual… https://t.co/8YGmGk6mX8
April 16th 2018, 12:04pm
Briefingcom @Briefingcom
$FATE: Fate Therapeutics to feature off-the-shelf CAR T-cell cancer immunotherapy, FT819, at 2018 AACR Annual... https://t.co/8ps2haySoB
April 16th 2018, 11:04am
JasonHolman5 @JasonHolman5
https://t.co/Qa49rf1G9F $FATE updated Corp. Pres.,comprehensive. Pgms across both I-O&Immuno Reg,1st slide on APOLL… https://t.co/efr09W3MtR
April 16th 2018, 11:04am
dhovekamp42 @dhovekamp42
RT @JasonHolman5: https://t.co/JJCZu0hGGr $FATE presenting their OTS CAR-T FT819 for CD19 at AACR, really focusingbon the manufacturing pot…
April 16th 2018, 11:04am
JasonHolman5 @JasonHolman5
https://t.co/JJCZu0hGGr $FATE presenting their OTS CAR-T FT819 for CD19 at AACR, really focusingbon the manufacturi… https://t.co/btVGQAFAnG
April 16th 2018, 11:04am
BTLipschultz @BTLipschultz
Interesting preclinical presentation from $fate for an off the shelf CAR T that will probably be in the IND stage in the next 12mths #aacr18
April 16th 2018, 10:04am
CI4CC @CI4CC
RT @BioStocks: $FATE Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at #AACR18 https://t.co/b1VteDsukp
April 16th 2018, 10:04am
CI4CC @CI4CC
RT @odibro: $FATE Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at #AACR18 https://t.co/G347y0Ym3v
April 16th 2018, 10:04am
odibro @odibro
$FATE Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at #AACR18 https://t.co/G347y0Ym3v
April 16th 2018, 9:04am
BioStocks @BioStocks
$FATE Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at #AACR18 https://t.co/b1VteDsukp
April 16th 2018, 9:04am
stockelite @stockelite
$FATE Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR Annual… https://t.co/W0EcLijTtP
April 16th 2018, 9:04am
livetraderalrt @livetraderalrt
$FATE 2.1m ago: Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AA… https://t.co/HOwE3GFWoN
April 16th 2018, 9:04am
BoerseGer @BoerseGer
$FATE Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR Annual… https://t.co/W0O8BMKJBm
April 16th 2018, 9:04am
GNWLive @GNWLive
Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR $FATE https://t.co/kCrcrlw0GX
April 16th 2018, 9:04am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.